Clinical trial
Gemcabene for the Treatment of Pediatric NAFLD: A Phase 2a Study
NCT03436420 is registered in ClinicalTrials.gov with Emory University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Gemcabene for the Treatment of Pediatric NAFLD: A Phase 2a Study
- Lead sponsor
- Emory University
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- March 29, 2018
- Completion date
- August 27, 2019
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.